Micro RNA ‐134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA / VEGFR 1 pathway-Reference-Cited by-同舟云学术

Micro RNA ‐134 inhibits osteosarcoma angiogenesis and proliferation by targeting the VEGFA / VEGFR 1 pathway

Published:2018-03-23 Issue:7 Volume:285 Page:1359-1371
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Zhang Long¹,Lv Zhi²,Xu Jing¹,Chen Chenglong¹,Ge Qiaofeng¹,Li Pengcui²,Wei Dinglu¹,Wu Zhuangzhuang²,Sun Xiaojuan²

Affiliation:

1. Shanxi Medical University Taiyuan China

2. Department of Orthopaedics The Second Hospital of Shanxi Medical University Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair Taiyuan China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.14416

Reference48 articles.

1. Osteosarcoma incidence and survival rates from 1973 to 2004

2. The Epidemiology of Osteosarcoma

3. Update on Survival in Osteosarcoma

4. The role of angiogenesis in tumor growth;Folkman J;Semin Cancer Biol,1992

5. Phase I dose‐escalating study of SU11654, a small molecule receptor tyrosine kinase inhibitor, in dogs with spontaneous malignancies;London CA;Clin Cancer Res,2003

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anoikis-related gene signature predicts survival and correlates with immune infiltration in osteosarcoma;Aging;2024-01-12

2. miRNA signaling networks of therapeutic interest involved in angiogenesis regulation by cancer stem cells;Cancer Stem Cells and Signaling Pathways;2024

3. Sex, Endothelial Cell Functions, and Peripheral Artery Disease;International Journal of Molecular Sciences;2023-12-13

4. Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking;Orthopaedic Surgery;2023-12-12

5. The correlation between clinical outcomes and genomic analysis with high risk factors for the progression of osteosarcoma;Molecular Oncology;2023-10-04